Integrated Pharmaceuticals, Inc. Announces its First Product Shipment
January 05 2005 - 11:33AM
PR Newswire (US)
Integrated Pharmaceuticals, Inc. Announces its First Product
Shipment FITCHBURG, Mass, Jan. 5 /PRNewswire-FirstCall/ --
Integrated Pharmaceuticals, Inc. (IntePharm) (OTC.PK: INTP)
announced that in December 2004 it completed its first commercial
shipment of products made at its new production facility in
Fitchburg, MA. IntePharm started construction of its Fitchburg
facility in the spring of 2004. The shipment of this product
represents a major milestone for the Company, demonstrating the
scalability of its technology, the readiness of its production
facility, and the effectiveness of its sales team. Dr. Chinmay
Chatterjee, Ph.D., President and CEO of IntePharm said: "We are
excited about having reached this milestone. We are also in
discussions with several other potential customers. These
discussions are at various stages of approval and negotiations
concerning sales terms and conditions." Dr. Chatterjee continued:
"IntePharm takes pride in providing the highest quality products to
its customers. In order to maintain these high standards, all of
IntePharm's products and product ingredients must pass a series of
strict quality control tests to confirm that our products meet the
appropriate level of quality. Our commitment to quality is
unsurpassed." About the Company IntePharm is an emerging producer
of pharmaceuticals, specialty compounds and chemicals for the
pharmaceutical, neutraceutical and food industries. In addition to
making products, IntePharm discovers and develops more efficient
and cost-effective manufacturing processes. These processes are
developed using a comprehensive technology platform that combines
metabolic engineering, cellular genetics, advanced bioprocess
engineering, and computer simulation science. For further
information please contact Dr. Chinmay Chatterjee, Integrated
Pharmaceuticals, Inc. (IntePharm), at (978) 696-0020, or visit
http://www.intepharm.com/. Forward-Looking Statements Certain
statements contained in this press release that are not historical
facts constitute "Forward-Looking Statements" within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements, in general, predict, indicate or imply
future results, performance or achievements and generally use words
so indicative. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause the
actual results or performance of the Company and its business to be
materially different from that expressed or implied by such
forward-looking statements. Included in those factors are the
following: our dependence on a limited number of potential
customers; limited managerial experience of our executives;
possible needs for additional capital; possible delays in product
development and delivery schedules; deferred or lost sales because
of the complex sales process prevalent in the industries that we
seek to serve; increased competitive pressure; and rapid
technological changes. Forward-looking statements by their very
nature are uncertain. There can be no guarantee that any
forward-looking statement will be fulfilled. The Company assumes no
obligation to update forward-looking statements to reflect actual
results or changes in or additions to the factors affecting such
forward- looking statements. DATASOURCE: Integrated
Pharmaceuticals, Inc. CONTACT: Dr. Chinmay Chatterjee, President
and CEO of Integrated Pharmaceuticals, Inc., +1-978-696-0020 Web
site: http://www.intepharm.com/
Copyright